Prophylactic treatment with the BH3 mimetic ABT-737 impedes Myc-driven lymphomagenesis in mice
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prophylactic treatment with the BH3 mimetic ABT-737 impedes Myc-driven lymphomagenesis in mice
Authors
Keywords
-
Journal
CELL DEATH AND DIFFERENTIATION
Volume 20, Issue 1, Pages 57-63
Publisher
Springer Nature
Online
2012-07-20
DOI
10.1038/cdd.2012.92
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia
- (2011) F. W. van Delft et al. BLOOD
- Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice
- (2011) P. N. Kelly et al. BLOOD
- Pharmacological blockade of Bcl-2, Bcl-xL and Bcl-w by the BH3 mimetic ABT-737 has only minor impact on tumour development in p53-deficient mice
- (2011) S Grabow et al. CELL DEATH AND DIFFERENTIATION
- Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases
- (2011) Andreas Strasser et al. EMBO JOURNAL
- Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease
- (2011) Andrew W. Roberts et al. JOURNAL OF CLINICAL ONCOLOGY
- Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
- (2011) Ingrid E. Wertz et al. NATURE
- Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim
- (2010) L. Happo et al. BLOOD
- The landscape of somatic copy-number alteration across human cancers
- (2010) Rameen Beroukhim et al. NATURE
- BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins represent another class of selective immune modulatory drugs
- (2010) E. M. Carrington et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mcl-1 Is Essential for Germinal Center Formation and B Cell Memory
- (2010) I. Vikstrom et al. SCIENCE
- Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis
- (2009) E M Michalak et al. CELL DEATH AND DIFFERENTIATION
- The role of BH3-only protein Bim extends beyond inhibiting Bcl-2–like prosurvival proteins
- (2009) Delphine Mérino et al. JOURNAL OF CELL BIOLOGY
- Mechanisms promoting translocations in editing and switching peripheral B cells
- (2009) Jing H. Wang et al. NATURE
- Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
- (2009) Martin Schwickart et al. NATURE
- ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
- (2008) C. Tse et al. CANCER RESEARCH
- Selection against PUMA Gene Expression in Myc-Driven B-Cell Lymphomagenesis
- (2008) S. P. Garrison et al. MOLECULAR AND CELLULAR BIOLOGY
- BCL-2 family antagonists for cancer therapy
- (2008) Guillaume Lessene et al. NATURE REVIEWS DRUG DISCOVERY
- In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas
- (2008) K. D. Mason et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
- (2008) C. G. Mullighan et al. SCIENCE
- How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?
- (2008) Jerry E. Chipuk et al. TRENDS IN CELL BIOLOGY
- The BCL-2 protein family: opposing activities that mediate cell death
- (2007) Richard J. Youle et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search